Following the successful launch of the inaugural event, the World #OrphanDrug Congress 2011 is set to become one of the leading forums for the orphan and rare disease community attracting a diverse representation of all stakeholders.
WHAT IS NEW FOR 2011?
MARKET ACCESS STRATEGY – INCREASED FOCUS ON GETTING THE TREATMENT TO THE PATIENT
The issue of pricing and reimbursement of orphan drugs is limiting the patient access to potentially life-changing treatments. Expert presentations, in depth Q&A sessions and interactive panel discussions evaluating the value of orphan drugs will allow all attendees to contribute to the congress.
A MORE COLLABORATIVE APPROACH
Recent global collaborations to foster innovation of rare disease treatments; an increased presence of rare disease patient organisations and international alliances; success stories exemplifying the integral contribution of all stakeholders during orphan drug development.
Please enjoy this advanced preview of the meeting agenda.
The World Orphan Drug Congress 2011 team
PS – We do have limited exhibition and sponsorship opportunities available. Please contact us now for details